← Leaderboards
David B Peden
University Of North Carolina Chapel Hill
$24,843,616
Attributed
$26,577,595
Total exposure
27
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,752,515 · 30
By mechanism
P01$20,119,715 · 5
R01$12,946,390 · 6
U19$12,137,243 · 5
T32$3,467,958 · 1
P50$3,004,964 · 1
RC1$976,772 · 1
Top collaborators
- John W Sleasman9 shared
- Richard C Boucher5 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Richard C Boucher$55,332,929
- Scott H Donaldson$8,054,486
- Scott H Randell$11,007,731
- Zhi Liu$9,856,482
- Wanda K O'Neal$8,008,262
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaInflammationEndotoxinsSputumAllergensAcuteResponseBreathingReportingProtocols DocumentationAirway InflammationMucociliary ClearanceVolunteerMonocyteAllergicMucous Body SubstanceDoseLungNeutrophilMediator Of Activation ProteinSamplingCellsAnimalsLung Diseases
Grant awards (101)
Research Training in Allergy and Clinical Immunology$486,806
T32 · FY2025 · AI · contact PI
Research Training in Allergy and Clinical Immunology$400,879
T32 · FY2024 · AI · contact PI
Research Training in Allergy and Clinical Immunology$443,911
T32 · FY2023 · AI · contact PI
Research Training in Allergy and Clinical Immunology$424,259
T32 · FY2022 · AI · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,173,966
P01 · FY2021 · HL · contact PI
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic$305,312
P01 · FY2021 · HL · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,173,973
P01 · FY2020 · HL · contact PI
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation$554,961
R01 · FY2020 · ES · contact PI
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic$347,224
P01 · FY2020 · HL · contact PI
Research Training in Allergy and Clinical Immunology$325,292
T32 · FY2020 · AI
Development of Novel Mycolytic Therapies for Lung Disease$1,826,101
P01 · FY2019 · HL · contact PI
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation$554,961
R01 · FY2019 · ES · contact PI
Research Training in Allergy and Clinical Immunology$352,781
T32 · FY2019 · AI
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic$269,724
P01 · FY2019 · HL · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,446,101
P01 · FY2018 · HL · contact PI
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation$580,801
R01 · FY2018 · ES · contact PI
Research Training in Allergy and Clinical Immunology$349,474
T32 · FY2018 · AI
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic$347,224
P01 · FY2018 · HL · contact PI
Development of Novel Mycolytic Therapies for Lung Disease$2,452,224
P01 · FY2017 · HL · contact PI
Phase II studies of gamma tocopherol as an intervention for environmental asthma$874,100
R01 · FY2017 · ES · contact PI
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation$554,961
R01 · FY2017 · ES · contact PI
Project 4: Treatment of mucostasis and airways obstruction in asthma with a novel mucolytic$349,323
P01 · FY2017 · HL · contact PI
Research Training in Allergy and Clinical Immunology$313,430
T32 · FY2017 · AI
Phase II studies of gamma tocopherol as an intervention for environmental asthma$877,260
R01 · FY2016 · ES · contact PI
Gamma tocopherol chemoprevention of wood smoke PM2.5-induced airway inflammation$580,801
R01 · FY2016 · ES · contact PI
Research Training in Allergy and Clinical Immunology$371,126
T32 · FY2016 · AI
Phase II studies of gamma tocopherol as an intervention for environmental asthma$503,809
R01 · FY2015 · ES · contact PI
Phase II studies of gamma tocopherol as an intervention for environmental asthma$386,591
R01 · FY2015 · ES · contact PI
Phase II studies of gamma tocopherol as an intervention for environmental asthma$515,177
R01 · FY2014 · ES · contact PI
Phase II studies of gamma tocopherol as an intervention for environmental asthma$526,078
R01 · FY2013 · ES · contact PI
Airway Biology of Acute Environmental Asthma in Humans$186,113
U19 · FY2013 · AI · contact PI
Immunobiology of Acute Environmental Asthma$186,113
U19 · FY2013 · AI · contact PI
Immunobiology of Acute Environmental Asthma$1,539,754
U19 · FY2012 · AI · contact PI
Airway Biology of Acute Environmental Asthma in Humans$430,958
U19 · FY2012 · AI · contact PI
Administrative Core$163,524
U19 · FY2012 · AI · contact PI
Immunobiology of Acute Environmental Asthma$1,547,479
U19 · FY2011 · AI · contact PI
Airway Biology of Acute Environmental Asthma in Humans$374,335
U19 · FY2011 · AI · contact PI
Administrative Core$142,832
U19 · FY2011 · AI · contact PI
Immunobiology of Acute Environmental Asthma$1,807,207
U19 · FY2010 · AI · contact PI
Smoking and airway innate host defense: in vivo studies$662,158
P50 · FY2010 · HL · contact PI
Investigating gene x environment interaction using human exposures to O3 & LPS$492,776
RC1 · FY2010 · ES · contact PI
Airway Biology of Acute Environmental Asthma in Humans$437,987
U19 · FY2010 · AI · contact PI
Immunobiology of Acute Environmental Asthma$218,863
U19 · FY2010 · AI · contact PI
Administrative Core$167,023
U19 · FY2010 · AI · contact PI
Immunobiology of Acute Environmental Asthma$1,553,641
U19 · FY2009 · AI · contact PI
Immunobiology of Acute Environmental Asthma$852,000
U19 · FY2009 · AI · contact PI
Smoking and airway innate host defense: in vivo studies$646,855
P50 · FY2009 · HL · contact PI
Investigating gene x environment interaction using human exposures to O3 & LPS$483,996
RC1 · FY2009 · ES · contact PI
Airway Biology of Acute Environmental Asthma in Humans$377,241
U19 · FY2009 · AI · contact PI
Administrative Core$143,246
U19 · FY2009 · AI · contact PI
Immunobiology of Acute Environmental Asthma$1,504,121
U19 · FY2008 · AI · contact PI
Translational Research Center for CAM Therapy of Asthma$1,151,035
P01 · FY2008 · AT · contact PI
Smoking and airway innate host defense: in vivo studies$619,582
P50 · FY2008 · HL · contact PI
Airway Biology of Acute Asthma: Translational Studies$474,831
R01 · FY2008 · HL · contact PI
Airway Biology of Acute Environmental Asthma in Humans$367,357
U19 · FY2008 · AI · contact PI
Project 1 - Phase I Clinical Screening of CAM Therapies for Asthma$309,455
P01 · FY2008 · AT · contact PI
Ozone and LPS-Induced Airway Inflammation In Humans In Vivo$300,195
R01 · FY2008 · ES · contact PI
Administrative Core$137,449
U19 · FY2008 · AI · contact PI
CLINICAL TRIAL: PHASE 1 STUDY OF DERMATOPHAGOIDES FARINAE INHALATION IN HUMANS$1,760
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: RANGE OF NEUTROPHIL RESPONSE TO 10,000 EU OF ENDOTOXIN IN HEALTH$459
M01 · FY2008 · RR · contact PI
Translational Research Center for CAM Therapy of Asthma$1,171,507
P01 · FY2007 · AT · contact PI
Smoking and airway innate host defense: in vivo studies$622,976
P50 · FY2007 · HL · contact PI
Airway Biology of Acute Asthma: Translational Studies$484,521
R01 · FY2007 · HL · contact PI
Project 1 - Phase I Clinical Screening of CAM Therapies for Asthma$307,889
P01 · FY2007 · AT · contact PI
Ozone and LPS-Induced Airway Inflammation In Humans In Vivo$300,587
R01 · FY2007 · ES · contact PI
EFFECT OF ALPHA TOCOPHEROL AND ASCORBATE SUPPLEMENTATION IN ASTHMATICS$38,454
M01 · FY2007 · RR · contact PI
SAFETY AND DOSE ESCALATION STUDY OF ENDOTOXIN IN ALLERGIC/ASTHAMATIC ADULTS$3,189
M01 · FY2007 · RR · contact PI
DOSE RANGING STUDY TO DETERMINE THE EFFECT OF A 20,000 EU DOSE OF INHALED CCRE$375
M01 · FY2007 · RR · contact PI
Translational Research Center for CAM Therapy of Asthma$1,171,757
P01 · FY2006 · AT · contact PI
Airway Biology of Acute Asthma: Translational Studies$498,992
R01 · FY2006 · HL · contact PI
Smoking and airway innate host defense: in vivo studies$453,393
P50 · FY2006 · HL · contact PI
O3 and LPS-Induced Airway Inflammation In Humans In Vivo$303,882
R01 · FY2006 · ES · contact PI
Project 1 - Phase I Clinical Screening of CAM Therapies for Asthma$277,332
P01 · FY2006 · AT · contact PI
EFFECT OF ALPHA TOCOPHEROL AND ASCORBATE SUPPLEMENTATION IN ASTHMATICS$8,921
M01 · FY2006 · RR · contact PI
SAFETY AND DOSE ESCALATION STUDY OF ENDOTOXIN IN ALLERGIC/ASTHAMATIC ADULTS$3,717
M01 · FY2006 · RR · contact PI
GSTMI GENOTYPE ASSOCIATED SUSCEPTIBILITY IN AIRWAY RESPONSE TO OZONE$248
M01 · FY2006 · RR · contact PI
Translational Research Center for CAM Therapy of Asthma$1,199,396
P01 · FY2005 · AT
Airway Biology of Acute Asthma: Translational Studies$511,000
R01 · FY2005 · HL
O3 and LPS-Induced Airway Inflammation In Humans In Vivo$305,598
R01 · FY2005 · ES
Endotoxin and Bronchial Inflammation in Asthma$291,000
R01 · FY2005 · HL
Project 1 - Phase I Clinical Screening of CAM Therapies for Asthma$272,929
P01 · FY2005 · AT
DOSE RANGING STUDY TO DETERMINE THE EFFECT OF A 20,000 EU DOSE OF INHALED CCRE$6,283
M01 · FY2005 · RR
SAFETY AND DOSE ESCALATION STUDY OF ENDOTOXIN IN ALLERGIC/ASTHAMATIC ADULTS$942
M01 · FY2005 · RR
ALLERGEN-INDUCED NASAL INFLAMMATION ON BRONCHIAL AIRWAY INFLAMMATION IN ASTHMATI$314
M01 · FY2005 · RR
Translational Research Center for CAM Therapy of Asthma$1,199,682
P01 · FY2004 · AT
Ozone and LPS-Induced Airway Inflammation In Humans$300,223
R01 · FY2004 · ES
Endotoxin and Bronchial Inflammation in Asthma$291,000
R01 · FY2004 · HL
Project 1 - Phase I Clinical Screening of CAM Therapies for Asthma$267,227
P01 · FY2004 · AT
Administrative Core$100,334
P01 · FY2004 · AT
Safety/Dose Escalation Study of Clinical Center Reference Endotoxin/Healthy Adul$19,528
M01 · FY2004 · RR
Safety and Dose Escalation Study of Endotoxin in Allergic/Asthamatic Adults$9,906
M01 · FY2004 · RR
Dose Ranging Study to Determine the Effect of a 20,000 EU Dose of Inhaled CCRE$5,377
M01 · FY2004 · RR
CD14 AND LPS-INDUCED INFLAMMATION IN CHRONIC BRONCHITIS$327,375
R01 · FY2003 · HL
Endotoxin and Bronchial Inflammation in Asthma$291,000
R01 · FY2003 · HL
CD14 AND LPS-INDUCED INFLAMMATION IN CHRONIC BRONCHITIS$327,375
R01 · FY2002 · HL
Endotoxin and Bronchial Inflammation in Asthma$291,000
R01 · FY2002 · HL
CD14 AND LPS-INDUCED INFLAMMATION IN CHRONIC BRONCHITIS$327,375
R01 · FY2001 · HL
ENDOTOXIN AND BRONCHIAL INFLAMMATION IN ASTHMA$246,797
R01 · FY2001 · HL
CD14 AND LPS-INDUCED INFLAMMATION IN CHRONIC BRONCHITIS$326,532
R01 · FY2000 · HL
ENDOTOXIN AND BRONCHIAL INFLAMMATION IN ASTHMA$237,607
R01 · FY2000 · HL
INHALED EXDOTOXIN IN BRONCHIAL INFLAMMATION IN ASTHMATICS$0
M01 · FY2000 · RR